# China’s Central Bank Pauses Short‑Term Cash Injections, Testing Markets’ Nerves Over Policy Support

*Tuesday, August 11, 2026 at 6:12 AM UTC — Hamer Intelligence Services Desk*

**Published**: 2026-08-11T06:12:49.540Z (3h ago)
**Category**: markets | **Region**: Global
**Importance**: 7/10
**Sources**: OSINT
**Permalink**: https://hamerintel.com/data/articles/13941.md
**Source**: https://hamerintel.com/summaries

---

**Deck**: China’s central bank has halted short‑term liquidity injections for the first time since June, a small technical move that could signal a shift in how Beijing manages a fragile economy and a heavy debt load. For investors, the pause raises questions over the level of support the People’s Bank of China is willing to provide as growth weakens and global rates stay high.

China has quietly tapped the brakes on one of the main tools it uses to reassure markets that cash will keep flowing through its financial system. For the first time since June, the People’s Bank of China has stopped injecting short‑term liquidity, a step that may be modest in scale but looms large as a potential signal of changing priorities in the world’s second‑largest economy. Short‑term liquidity operations—typically conducted through reverse repurchase agreements in the open market—are the plumbing that ensures Chinese banks have enough cash to meet daily funding needs. By pausing these injections, even briefly, the PBoC is effectively testing whether the system can function with less visible…

---

*Full article available with Hamer Intel Pro — https://hamerintel.com/pricing*